| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |